X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31271) 31271
Publication (2394) 2394
Book Review (375) 375
Book / eBook (273) 273
Book Chapter (236) 236
Newsletter (77) 77
Conference Proceeding (53) 53
Magazine Article (26) 26
Dissertation (24) 24
Data Set (11) 11
Paper (4) 4
Newspaper Article (3) 3
Reference (3) 3
Trade Publication Article (3) 3
Web Resource (3) 3
Transcript (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24593) 24593
male (18932) 18932
female (15409) 15409
middle aged (12054) 12054
index medicus (11916) 11916
aged (10863) 10863
clinical neurology (10103) 10103
stroke (9284) 9284
adult (8086) 8086
neurosciences (5782) 5782
risk factors (5453) 5453
magnetic resonance imaging (5196) 5196
animals (4848) 4848
cerebral infarction - etiology (4357) 4357
cerebral infarction - complications (4352) 4352
cerebral infarction (4293) 4293
surgery (4216) 4216
tomography, x-ray computed (3971) 3971
aged, 80 and over (3747) 3747
treatment outcome (3627) 3627
peripheral vascular disease (3511) 3511
brain (3231) 3231
ischemia (3185) 3185
neurology (2903) 2903
rats (2852) 2852
retrospective studies (2701) 2701
cerebral angiography (2568) 2568
time factors (2484) 2484
infarction (2438) 2438
brain - pathology (2390) 2390
brain ischemia - complications (2336) 2336
stroke - etiology (2334) 2334
cerebral infarction - diagnosis (2178) 2178
adolescent (2135) 2135
care and treatment (2075) 2075
prognosis (2042) 2042
research (2013) 2013
cerebral infarction - pathology (1967) 1967
disease models, animal (1967) 1967
stroke - complications (1958) 1958
follow-up studies (1948) 1948
mortality (1928) 1928
prospective studies (1809) 1809
infarction, middle cerebral artery - complications (1788) 1788
cerebral ischemia (1775) 1775
risk (1727) 1727
diagnosis (1673) 1673
cerebral infarction - diagnostic imaging (1642) 1642
child (1605) 1605
health aspects (1543) 1543
cardiovascular diseases (1541) 1541
patients (1514) 1514
hemorrhage (1459) 1459
disease (1445) 1445
subarachnoid hemorrhage (1442) 1442
brain ischemia - etiology (1438) 1438
complications and side effects (1416) 1416
neuroimaging (1407) 1407
medicine, general & internal (1367) 1367
hypertension (1300) 1300
medicine (1296) 1296
complications (1291) 1291
analysis (1288) 1288
rats, sprague-dawley (1281) 1281
pediatrics (1253) 1253
severity of illness index (1236) 1236
cerebral hemorrhage - etiology (1226) 1226
ischemic stroke (1224) 1224
mice (1207) 1207
risk-factors (1200) 1200
hypertension - complications (1192) 1192
radiology, nuclear medicine & medical imaging (1166) 1166
cerebral hemorrhage - complications (1157) 1157
therapy (1157) 1157
cerebral infarction - physiopathology (1148) 1148
research article (1141) 1141
acute disease (1138) 1138
brain ischemia - pathology (1120) 1120
magnetic resonance angiography (1115) 1115
acute ischemic-stroke (1106) 1106
cerebrovascular circulation (1102) 1102
veins & arteries (1076) 1076
management (1068) 1068
medical imaging (1061) 1061
cardiac & cardiovascular systems (1055) 1055
stroke - pathology (1055) 1055
myocardial infarction (1053) 1053
diagnosis, differential (1050) 1050
ischemic-stroke (1049) 1049
medicine & public health (1036) 1036
child, preschool (1028) 1028
psychiatry (1022) 1022
studies (1007) 1007
stroke - physiopathology (996) 996
inflammation (977) 977
neurosurgery (972) 972
cerebral blood flow (969) 969
abridged index medicus (964) 964
thrombosis (958) 958
hematology (956) 956
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (214) 214
UTL at Downsview - May be requested (11) 11
OISE - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Holland Bloorview Kids Rehabilitation - Stacks (9) 9
UofT at Mississauga - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Baycrest Hospital - Stacks (6) 6
Online Resources - Online (6) 6
West Park Healthcare Centre - Stacks (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
St. Michael's Hospital - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Providence Healthcare - Reference (2) 2
West Park Healthcare Centre - Hospital Department (2) 2
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Periodical Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Lost (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28358) 28358
Japanese (1231) 1231
Spanish (515) 515
German (514) 514
French (470) 470
Chinese (220) 220
Russian (196) 196
Polish (71) 71
Dutch (50) 50
Italian (50) 50
Portuguese (46) 46
Norwegian (33) 33
Danish (22) 22
Korean (18) 18
Finnish (16) 16
Hungarian (13) 13
Swedish (12) 12
Serbian (9) 9
Czech (8) 8
Croatian (7) 7
Romanian (5) 5
Hebrew (4) 4
Turkish (4) 4
Lithuanian (3) 3
Bosnian (2) 2
Slovak (2) 2
Arabic (1) 1
Bulgarian (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 1, pp. 11 - 21
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1287 - 1296
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 23, pp. 2247 - 2257
In this randomized study, the addition of lixisenatide, a glucagon-like peptide 1–receptor agonist, to usual care in patients with type 2 diabetes and a recent... 
MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | GLUCAGON-LIKE PEPTIDE-1 | MYOCARDIAL-INFARCTION | CARDIOVASCULAR OUTCOMES | RECEPTOR AGONISTS | GLUCOSE | DOUBLE-BLIND | FOLLOW-UP | MELLITUS | CONGESTIVE-HEART-FAILURE | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality
Journal Article